LONDON, Nov. 8, 2017 /PRNewswire/ --
Malaria, Dengue, Leishmaniasis, Schistosomiasis, Lymphatic Filariasis, Chagas DiseaseReport DetailsDownload the full report: https://www.reportbuyer.com/product/5184204The Global Treatment for Neglected Tropical Disease market is expected to grow at a CAGR of 7.3% in the second half of the forecast period. The Global Treatment for Neglected Tropical Disease market reached $1.5bn in 2016, dominated by the treatments for malaria which held 30% share of the market.How this report will benefit youRead on to discover how you can exploit the future business opportunities emerging in this sector.In this brand new 157-page report you will receive 71 tables and 80 figures– all unavailable elsewhere.The 157-page report provides clear detailed insight into the Global Treatment for Neglected Tropical Disease market. Discover the key drivers and challenges affecting the market.By ordering and reading our brand-new report today you stay better informed and ready to act.Report Scope• Global Treatment for Neglected Tropical Disease market forecasts from 2017-2027This report also breaks down the revenue forecast for the Global Treatment for Neglected Tropical Disease market by disease type:- Malaria treatments- Dengue treatments- Leishmaniasis- Schistosomiasis- Lymphatic Filariasis- Chagas Disease- OthersFor each disease type, the report provides a SWOT analysis, a list of selected drugs and revenue forecasts from 2017-2027 of the leading drugs.This report provides revenue forecast for these leading drugs:- Coartem (Novartis)- Clindamycin (Pfizer)- Dengvaxia (Sanofi)- AmBisome (Gilead Sciences)- Impavido (Knight Therapeutics)- ALBENZA (Amedra Pharmaceuticals LLC)This report also breaks down the revenue forecast for the Global Treatment for Neglected Tropical Disease market by regional and national market:- North America: US and Canada- Europe: Germany, the UK, France, Spain, Italy, Rest of Europe- Asia-Pacific: Japan, China, India, Rest of Asia- Latin America: Brazil, Mexico, Rest of Latin America- Middle East & Africa: Saudi Arabia, South of Africa, Rest of Middle East & AfricaEach regional market is further broken down by disease type.This report provides company overview, financial information, product portfolio and recent developments for the leading companies in the neglected tropical disease market:- Pfizer, Inc.- Bayer- GlaxoSmithKline plc- Merck & Co., Inc.- Novartis International AG- Takeda Pharmaceutical Company Ltd- Sanofi S.A.- Eisai Co., LtdDownload the full report: https://www.reportbuyer.com/product/5184204 About Reportbuyer Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers https://www.reportbuyer.com For more information: Sarah Smith Research Advisor at Reportbuyer.com Email: [email protected] Tel: +44 208 816 85 48 Website: www.reportbuyer.com
Advertisement
Malaria, Dengue, Leishmaniasis, Schistosomiasis, Lymphatic Filariasis, Chagas DiseaseReport DetailsDownload the full report: https://www.reportbuyer.com/product/5184204The Global Treatment for Neglected Tropical Disease market is expected to grow at a CAGR of 7.3% in the second half of the forecast period. The Global Treatment for Neglected Tropical Disease market reached $1.5bn in 2016, dominated by the treatments for malaria which held 30% share of the market.How this report will benefit youRead on to discover how you can exploit the future business opportunities emerging in this sector.In this brand new 157-page report you will receive 71 tables and 80 figures– all unavailable elsewhere.The 157-page report provides clear detailed insight into the Global Treatment for Neglected Tropical Disease market. Discover the key drivers and challenges affecting the market.By ordering and reading our brand-new report today you stay better informed and ready to act.Report Scope• Global Treatment for Neglected Tropical Disease market forecasts from 2017-2027This report also breaks down the revenue forecast for the Global Treatment for Neglected Tropical Disease market by disease type:- Malaria treatments- Dengue treatments- Leishmaniasis- Schistosomiasis- Lymphatic Filariasis- Chagas Disease- OthersFor each disease type, the report provides a SWOT analysis, a list of selected drugs and revenue forecasts from 2017-2027 of the leading drugs.This report provides revenue forecast for these leading drugs:- Coartem (Novartis)- Clindamycin (Pfizer)- Dengvaxia (Sanofi)- AmBisome (Gilead Sciences)- Impavido (Knight Therapeutics)- ALBENZA (Amedra Pharmaceuticals LLC)This report also breaks down the revenue forecast for the Global Treatment for Neglected Tropical Disease market by regional and national market:- North America: US and Canada- Europe: Germany, the UK, France, Spain, Italy, Rest of Europe- Asia-Pacific: Japan, China, India, Rest of Asia- Latin America: Brazil, Mexico, Rest of Latin America- Middle East & Africa: Saudi Arabia, South of Africa, Rest of Middle East & AfricaEach regional market is further broken down by disease type.This report provides company overview, financial information, product portfolio and recent developments for the leading companies in the neglected tropical disease market:- Pfizer, Inc.- Bayer- GlaxoSmithKline plc- Merck & Co., Inc.- Novartis International AG- Takeda Pharmaceutical Company Ltd- Sanofi S.A.- Eisai Co., LtdDownload the full report: https://www.reportbuyer.com/product/5184204 About Reportbuyer Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers https://www.reportbuyer.com For more information: Sarah Smith Research Advisor at Reportbuyer.com Email: [email protected] Tel: +44 208 816 85 48 Website: www.reportbuyer.com
View original content:http://www.prnewswire.com/news-releases/the-global-treatment-for-neglected-tropical-disease-market-reached-15bn-in-2016-300552220.html
SOURCE ReportBuyer
